AestheFill Lumps and Uneven Texture Six Months After Injection: Treatment and Minimally Invasive Solutions

Why Do Cheeks Become Bumpy Months After AestheFill?

AestheFill is a collagen-stimulating filler that has rapidly gained popularity across Asian markets. Its active ingredient — poly-D,L-lactic acid (PDLLA) microspheres — works similarly to Sculptra (PLLA) by stimulating the body's own collagen production to create volumization and skin tightening effects.

However, a significant number of patients find that three to six months after injection, the anticipated "natural plumpness" transforms into uneven cheek contours, palpable hard lumps, or even visible subcutaneous nodules. The shift from anticipation to distress leaves many patients feeling helpless.

Key Insight: Although AestheFill (PDLLA) and Sculptra (PLLA) share similar chemistry, their microsphere morphology and degradation kinetics differ — and these differences can influence the pattern and severity of complications.

Understanding AestheFill: Composition, Mechanism, and Risks

PDLLA Microsphere Characteristics

The core component of AestheFill is PDLLA microspheres. Unlike the pure L-form PLLA (Poly-L-Lactic Acid (Sculptra) — particle injection stimulating collagen) in Sculptra, PDLLA is a copolymer of both D- and L-lactic acid:

Why Uneven Texture Develops

The causes of post-AestheFill texture irregularity are multifactorial:

1. Technical Factors

   • Insufficient dilution: High microsphere concentration promotes aggregation
   • Uneven injection depth: Variable placement creates non-uniform collagen stimulation
   • Inconsistent injection speed: Some areas receive disproportionately dense deposits

2. Biological Factors

   • Individual collagen response varies significantly between patients
   • Local blood circulation affects degradation rate
   • Tissue tension differences lead to variable collagen growth patterns

3. Microsphere-Related Factors

   • Porous structure may provoke localized intense fibrosis
   • Microsphere aggregation forms "cores" that become excessively wrapped in collagen
   • Non-uniform degradation creates areas of persistent stimulation

Key Insight: Texture irregularity typically becomes apparent 2–6 months post-injection, coinciding with peak collagen production. The window between "looking great" and "growing concerned" can be alarmingly short.

Conventional Treatments and Their Limitations

5-FU (5-Fluorouracil) Injection

5-FU is an antimetabolite medication sometimes used to treat collagen stimulator nodules. It works by inhibiting fibroblast proliferation and reducing excessive collagen formation.

Steroid Injection

Intralesional steroid injection (triamcinolone) is also commonly attempted to soften nodules:

When 5-FU and Steroids Fail

Clinical experience shows that 5-FU and steroids have limited effectiveness in the following scenarios:

• Mature encapsulated lumps: Drugs cannot penetrate the fibrous barrier
• Heavily aggregated microsphere nodules: Medication reduces surrounding inflammation but the core material remains
• Multiple deep nodules: Superficial drug injections cannot reach deep lesions
• Nodules older than 6 months: Fibrosis (excess scar tissue formation) has stabilized; drug efficacy diminishes

Ultrasound-Guided Extraction: When Medical Treatment Reaches Its Limit

AestheFill Nodules on Ultrasound

AestheFill nodules display characteristic features on ultrasound imaging:

Indications for Extraction

Ultrasound-guided minimally invasive extraction should be considered when:

1. Three or more 5-FU sessions have produced no significant improvement
2. Steroid injections have caused skin atrophy while the lump persists
3. Nodules have been present for over 6 months and affect appearance
4. The patient cannot accept waiting 2–3 years for natural degradation
5. Superficial nodules are severely disrupting facial contour

The Extraction Process

Assessment Phase

• Detailed history: AestheFill batch, injection date, treatment areas, and dosage
• Ultrasound scan: Document all nodule locations, dimensions, depth, and capsule characteristics
• Discuss realistic expectations with the patient

Surgical Phase

• Local anesthesia
• 1–2mm pinhole incision
• Real-time ultrasound-guided approach to the nodule
• Fragment the capsule and extract aggregated PDLLA microspheres
• Ultrasound confirmation of extraction completeness

Post-Procedure Phase

• Light compression for 24–48 hours
• One-week follow-up
• Ultrasound monitoring at 1 month and 3 months

Expected Results

Preventing AestheFill Complications

Pre-Injection Evaluation

• Understand your skin thickness and tissue conditions
• Confirm the practitioner's experience with AestheFill specifically
• Discuss injection volume (less is more)
• Establish a plan for managing complications if they arise

The Importance of Injection Technique

Do Not Let Texture Irregularity Become a Long-Term Burden

If you are experiencing uneven cheeks, lumps, or nodules after AestheFill injection — and medical treatments have not delivered results — ultrasound-guided minimally invasive extraction may be the answer. Early professional evaluation is important to avoid cumulative tissue damage from repeated drug injections.

Further reading:

• Collagen Stimulator Nodules: What to Do When 5-FU Treatment Fails
• Sculptra Lumps: Options After Steroid Failure
• Minimally Invasive Filler Lump Extraction Technique

Book an ultrasound evaluation

About the Author

Dr. Ta-Ju Liu

• Current Position: Director, Liusmed Clinic
• Specialties: Minimally invasive surgery, filler complication repair, ultrasound-guided extraction
• Experience: 15+ years of clinical minimally invasive surgery; over 10,000 successful cases
• Philosophy: "Managing collagen stimulator complications requires patience and precision. Medical treatment has its role, but when medication reaches its limit, minimally invasive extraction provides the definitive answer."

Related Services

• Filler Complication Repair
• Aesthetic Repair Specialty